Results 11 to 20 of about 440,279 (349)

Hemodynamic assessment of congenital heart malformations with left to right shunt [PDF]

open access: yesБългарска кардиология, 2022
Cardiac catheterization with direct measurements of pressure and saturation in cardiac chambers and great vessels and calculation of systemic and pulmonary blood fl ow, pulmonary and systemic resistance, and pulmonary vascular reactivity are ...
Anna Kaneva
doaj   +3 more sources

Cinaciguat (BAY-582667) Modifies Cardiopulmonary and Systemic Circulation in Chronically Hypoxic and Pulmonary Hypertensive Neonatal Lambs in the Alto Andino

open access: yesFrontiers in Physiology, 2022
Neonatal pulmonary hypertension (NPHT) is produced by sustained pulmonary vasoconstriction and increased vascular remodeling. Soluble guanylyl cyclase (sGC) participates in signaling pathways that induce vascular vasodilation and reduce vascular ...
Felipe A. Beñaldo   +13 more
doaj   +1 more source

Behavior of vascular resistance undergoing various pressure insufflation and perfusion on decellularized lungs [PDF]

open access: yes, 2016
Bioengineering of functional lung tissue by using whole lung scaffolds has been proposed as a potential alternative for patients awaiting lung transplant.
Hideo Shiogama   +11 more
core   +10 more sources

Prediction of Operability by Pulmonary Artery Acceleration Time and Right Ventricular Ejection Time in Large Ventricular Septal Defects with Severe Pulmonary Arterial Hypertension

open access: yesJournal of the Indian Academy of Echocardiography & Cardiovascular Imaging, 2023
Background: Diagnosing and treating cardiopulmonary illnesses in children depend heavily on evaluating pulmonary hemodynamics. Severe pulmonary artery hypertension (PAH) and Eisenmenger's syndrome are most frequently seen in post-tricuspid shunts.
Sudipta Bandyopadhyay   +2 more
doaj   +1 more source

Pulmonary vascular resistance and clinical outcomes in patients with pulmonary hypertension: a retrospective cohort study.

open access: yesThe Lancet Respiratory Medicine, 2020
BACKGROUND In pulmonary hypertension subgroups, elevated pulmonary vascular resistance (PVR) of 3·0 Wood units or more is associated with poor prognosis. However, the spectrum of PVR risk in pulmonary hypertension is not known.
B. Maron   +17 more
semanticscholar   +1 more source

Latent Pulmonary Vascular Disease May Alter the Response to Therapeutic Atrial Shunt Device in Heart Failure

open access: yesCirculation, 2022
Background: In REDUCE LAP-HF II (A Study to Evaluate the Corvia Medical, Inc IASD System II to Reduce Elevated Left Atrial Pressure in Patients With Heart Failure), implantation of an atrial shunt device did not provide overall clinical benefit for ...
B. Borlaug   +35 more
semanticscholar   +1 more source

Nitric oxide and pulmonary hypertension [PDF]

open access: yesKorean Journal of Anesthesiology, 2010
Pulmonary hypertension is a serious complication of a number of lung and heart diseases that is characterized by peripheral vascular structural remodeling and loss of vascular tone.
Ji-Yeon Sim
doaj   +1 more source

Elevated pre‐transplant pulmonary vascular resistance is associated with early post‐transplant atrial fibrillation and mortality

open access: yesESC Heart Failure, 2020
Severely elevated pre‐transplant pulmonary vascular resistance (PVR) has been linked to adverse effects after heart transplantation (HTX). The impact of a moderately increased PVR before HTX on post‐transplant outcomes remains uncertain.
R. Rivinius   +9 more
semanticscholar   +1 more source

Mechanisms of Pulmonary Vascular Dysfunction in Pulmonary Hypertension and Implications for Novel Therapies.

open access: yesAmerican Journal of Physiology. Heart and Circulatory Physiology, 2022
Pulmonary Hypertension (PH) is a serious disease characterized by various degrees of pulmonary vasoconstriction and progressive fibro-proliferative remodeling and inflammation of the pulmonary arterioles that lead to increased pulmonary vascular ...
H. Christou, R. Khalil
semanticscholar   +1 more source

Chronic Inhibition of Toll‐Like Receptor 9 Ameliorates Pulmonary Hypertension in Rats

open access: yesJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2021
Background Recent accumulating evidence suggests that toll‐like receptor 9 (TLR9) is involved in the pathogenesis of cardiovascular diseases. However, its role in pulmonary hypertension remains uncertain.
Tomohito Ishikawa   +9 more
doaj   +1 more source

Home - About - Disclaimer - Privacy